PATENT CLAIM ANALYSIS

Application Number: 16192216
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-12
Patent Classification: ["514", "721000"]

Abstract:
Disclosed herein are hexadecaphlorethol (HdP), which is a novel compound isolated from  Ishige okamurae , and the use thereof in anti-diabetic treatment and exercise performance improvement. The novel compound HdP has the activity of inhibiting α-glucosidase, inducing glucose uptake into differentiated myoblast C2C12 cells, reducing blood glucose levels in zebrafish which have reduced insulin secretion through treatment with alloxan, increasing an intracellular level of calcium ions necessary for muscle contraction and exercise performance in zebrafish, and inducing uptake of glucose, an energy source necessary for muscle contraction, into cells.

Claim (Index 4):
The composition of  claim 2 , which is in a form of a pharmaceutical composition.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.53846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13179895', '11885450', '12927873', '13987048', '14330174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7085619416335875
- 35 USC 102 Novelty (BERT): 0.4932083157524007
- Combined Prediction Score: 0.6870265790454688
- Mean Citation Score: 147.859084
- Max Citation Score: 156.06104
- Similarity Product: 103.5823143085432

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test